Laura L. Mulloy

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

A. Osama Gaber, M. Roy First, Raymond J. Tesi et al. · Transplantation · 1998 · 301 citations

Life Sciences, Immunology, Nephrology +17

Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications

Marie A. Chisholm, Laura L. Mulloy, Muralidharan Jagadeesan et al. · Clinical Transplantation · 2001 · 179 citations

Medicine, Clinical Pharmacy, Nephrology +16

RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1

Marie A. Chisholm, Leslie J. Vollenweider, Laura L. Mulloy et al. · Transplantation · 2000 · 142 citations

Medicine, Nephrology, Pharmacology +17

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12

Joseph Lawen, Elizabeth Davies, Georges Mourad et al. · Transplantation · 2003 · 137 citations

Medicine, Immunology, Pharmacology +17

A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation

Rachel E. Patzer, Sudeshna Paul, Laura Plantinga et al. · Journal of the American Society of Nephrology · 2016 · 119 citations · Full text

Medicine, Community Health, Nephrology +16